Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds: II(1).

Environmental toxicology and pharmacology

Coleman MD, Rathbone DL, Endersby CR, Hovey MC, Tims KJ, Lambert PA, Billington DC.
PMID: 10925069
Environ Toxicol Pharmacol. 2000 Mar 01;8(3):167-172. doi: 10.1016/s1382-6689(00)00037-5.

The in vitro toxicity of two amidrazones I [N(1)-(3-benzyloxy-4-methoxybenzylidene)-pyridine-2-carboxamidrazone] and II [N(1)-(4-benzyloxy-3-methoxybenzylidene)-pyridine-2-carboxamidrazone] and their precursors PI (3-benzyloxy-4-methoxybenzaldehyde) and PII (4-benzyloxy-3-methoxybenzaldehyde) was determined using a rat liver metabolism system with human mononuclear leucocytes (MNL) as target cells. The minimum inhibitory...

Cite
Coleman MD, Rathbone DL, Endersby CR, et al. Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds: II(1). Environ Toxicol Pharmacol. 2000;8(3):167-172doi: 10.1016/s1382-6689(00)00037-5.
Coleman, M. D., Rathbone, D. L., Endersby, C. R., Hovey, M. C., Tims, K. J., Lambert, P. A., & Billington, D. C. (2000). Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds: II(1). Environmental toxicology and pharmacology, 8(3), 167-172. https://doi.org/10.1016/s1382-6689(00)00037-5
Coleman, et al. "Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds: II(1)." Environmental toxicology and pharmacology vol. 8,3 (2000): 167-172. doi: https://doi.org/10.1016/s1382-6689(00)00037-5
Coleman MD, Rathbone DL, Endersby CR, Hovey MC, Tims KJ, Lambert PA, Billington DC. Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds: II(1). Environ Toxicol Pharmacol. 2000 Mar 01;8(3):167-172. doi: 10.1016/s1382-6689(00)00037-5. PMID: 10925069.
Copy Download .nbib Format: NLM
ATMOSPHERIC ELECTRICITY.

Science (New York, N.Y.)

Endersby VA, Foster DG.
PMID: 17809924
Science. 1929 Jul 12;70(1802):38-9. doi: 10.1126/science.70.1802.38.

No abstract available.

Cite
Endersby VA, Foster DG. ATMOSPHERIC ELECTRICITY. Science. 1929;70(1802):38-9doi: 10.1126/science.70.1802.38.
Endersby, V. A., & Foster, D. G. (1929). ATMOSPHERIC ELECTRICITY. Science (New York, N.Y.), 70(1802), 38-9. https://doi.org/10.1126/science.70.1802.38
Endersby, V A, and Foster, D G. "ATMOSPHERIC ELECTRICITY." Science (New York, N.Y.) vol. 70,1802 (1929): 38-9. doi: https://doi.org/10.1126/science.70.1802.38
Endersby VA, Foster DG. ATMOSPHERIC ELECTRICITY. Science. 1929 Jul 12;70(1802):38-9. doi: 10.1126/science.70.1802.38. PMID: 17809924.
Copy Download .nbib Format: NLM
A life more ordinary: the dull life but interesting times of joseph dalton hooker.

Journal of the history of biology

Endersby J.
PMID: 21336663
J Hist Biol. 2011;44(4):611-31. doi: 10.1007/s10739-011-9270-z.

The life of Joseph Dalton Hooker (1817-1911) provides an invaluable lens through which to view mid-Victorian science. A biographical approach makes it clear that some well-established narratives about this period need revising. For example, Hooker's career cannot be considered...

Cite
Endersby J. A life more ordinary: the dull life but interesting times of joseph dalton hooker. J Hist Biol. 2011;44(4):611-31doi: 10.1007/s10739-011-9270-z.
Endersby, J. (2011). A life more ordinary: the dull life but interesting times of joseph dalton hooker. Journal of the history of biology, 44(4), 611-31. https://doi.org/10.1007/s10739-011-9270-z
Endersby, Jim. "A life more ordinary: the dull life but interesting times of joseph dalton hooker." Journal of the history of biology vol. 44,4 (2011): 611-31. doi: https://doi.org/10.1007/s10739-011-9270-z
Endersby J. A life more ordinary: the dull life but interesting times of joseph dalton hooker. J Hist Biol. 2011;44(4):611-31. doi: 10.1007/s10739-011-9270-z. PMID: 21336663.
Copy Download .nbib Format: NLM
Leadership in interprofessional health and social care teams: a literature review.

Leadership in health services (Bradford, England)

Smith T, Fowler-Davis S, Nancarrow S, Ariss SMB, Enderby P.
PMID: 30234446
Leadersh Health Serv (Bradf Engl). 2018 Oct 01;31(4):452-467. doi: 10.1108/LHS-06-2016-0026. Epub 2018 Mar 15.

Purpose The purpose of this study is to review evidence on the nature of effective leadership in interprofessional health and social care teams. Design/methodology/approach A critical review and thematic synthesis of research literature conducted using systematic methods to identify...

Cite
Smith T, Fowler-Davis S, Nancarrow S, et al. Leadership in interprofessional health and social care teams: a literature review. Leadersh Health Serv (Bradf Engl). 2018;31(4):452-467doi: 10.1108/LHS-06-2016-0026.
Smith, T., Fowler-Davis, S., Nancarrow, S., Ariss, S. M. B., & Enderby, P. (2018). Leadership in interprofessional health and social care teams: a literature review. Leadership in health services (Bradford, England), 31(4), 452-467. https://doi.org/10.1108/LHS-06-2016-0026
Smith, Tony, et al. "Leadership in interprofessional health and social care teams: a literature review." Leadership in health services (Bradford, England) vol. 31,4 (2018): 452-467. doi: https://doi.org/10.1108/LHS-06-2016-0026
Smith T, Fowler-Davis S, Nancarrow S, Ariss SMB, Enderby P. Leadership in interprofessional health and social care teams: a literature review. Leadersh Health Serv (Bradf Engl). 2018 Oct 01;31(4):452-467. doi: 10.1108/LHS-06-2016-0026. Epub 2018 Mar 15. PMID: 30234446.
Copy Download .nbib Format: NLM
Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction.

The American journal of medicine

Bayoumi E, Lam PH, Enders R, Arundel C, Sheriff HM, Brar V, Jurgens CY, Deedwania P, Faselis C, Allman RM, Fonarow GC, Ahmed A.
PMID: 34861195
Am J Med. 2021 Nov 30; doi: 10.1016/j.amjmed.2021.11.004. Epub 2021 Nov 30.

BACKGROUND: Beta-blockers improve clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Less is known about their role in older nursing home residents with HFrEF.METHODS: From the combined OPTIMIZE-HF and Alabama Heart Failure Project datasets, we...

Cite
Bayoumi E, Lam PH, Enders R, et al. Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction. Am J Med. 2021;doi: 10.1016/j.amjmed.2021.11.004.
Bayoumi, E., Lam, P. H., Enders, R., Arundel, C., Sheriff, H. M., Brar, V., Jurgens, C. Y., Deedwania, P., Faselis, C., Allman, R. M., Fonarow, G. C., & Ahmed, A. (2021). Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction. The American journal of medicine, . https://doi.org/10.1016/j.amjmed.2021.11.004
Bayoumi, Essraa, et al. "Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction." The American journal of medicine vol. (2021). doi: https://doi.org/10.1016/j.amjmed.2021.11.004
Bayoumi E, Lam PH, Enders R, Arundel C, Sheriff HM, Brar V, Jurgens CY, Deedwania P, Faselis C, Allman RM, Fonarow GC, Ahmed A. Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction. Am J Med. 2021 Nov 30; doi: 10.1016/j.amjmed.2021.11.004. Epub 2021 Nov 30. PMID: 34861195.
Copy Download .nbib Format: NLM
Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction.

The American journal of medicine

Bayoumi E, Lam PH, Enders R, Arundel C, Sheriff HM, Brar V, Jurgens CY, Deedwania P, Faselis C, Allman RM, Fonarow GC, Ahmed A.
PMID: 34861195
Am J Med. 2021 Nov 30; doi: 10.1016/j.amjmed.2021.11.004. Epub 2021 Nov 30.

BACKGROUND: Beta-blockers improve clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Less is known about their role in older nursing home residents with HFrEF.METHODS: From the combined OPTIMIZE-HF and Alabama Heart Failure Project data sets,...

Cite
Bayoumi E, Lam PH, Enders R, et al. Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction. Am J Med. 2021;doi: 10.1016/j.amjmed.2021.11.004.
Bayoumi, E., Lam, P. H., Enders, R., Arundel, C., Sheriff, H. M., Brar, V., Jurgens, C. Y., Deedwania, P., Faselis, C., Allman, R. M., Fonarow, G. C., & Ahmed, A. (2021). Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction. The American journal of medicine, . https://doi.org/10.1016/j.amjmed.2021.11.004
Bayoumi, Essraa, et al. "Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction." The American journal of medicine vol. (2021). doi: https://doi.org/10.1016/j.amjmed.2021.11.004
Bayoumi E, Lam PH, Enders R, Arundel C, Sheriff HM, Brar V, Jurgens CY, Deedwania P, Faselis C, Allman RM, Fonarow GC, Ahmed A. Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction. Am J Med. 2021 Nov 30; doi: 10.1016/j.amjmed.2021.11.004. Epub 2021 Nov 30. PMID: 34861195.
Copy Download .nbib Format: NLM
Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia.

Clinical & translational immunology

Foley B, Ta C, Barnes S, de Jong E, Nguyen M, Cheung LC, Buzzai A, Wagner T, Wylie B, Fernandez S, Cruickshank M, Endersby R, Kees U, Waithman J.
PMID: 32695339
Clin Transl Immunology. 2020 Jul 16;9(7):e1151. doi: 10.1002/cti2.1151. eCollection 2020.

OBJECTIVES: Natural killer (NK) cells are an attractive source of cells for an 'off the shelf' cellular therapy because of their innate capacity to target malignant cells, and ability to be transferred between donors and patients. However, since not...

Cite
Foley B, Ta C, Barnes S, et al. Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia. Clin Transl Immunology. 2020;9(7):e1151doi: 10.1002/cti2.1151.
Foley, B., Ta, C., Barnes, S., de Jong, E., Nguyen, M., Cheung, L. C., Buzzai, A., Wagner, T., Wylie, B., Fernandez, S., Cruickshank, M., Endersby, R., Kees, U., & Waithman, J. (2020). Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia. Clinical & translational immunology, 9(7), e1151. https://doi.org/10.1002/cti2.1151
Foley, Bree, et al. "Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia." Clinical & translational immunology vol. 9,7 (2020): e1151. doi: https://doi.org/10.1002/cti2.1151
Foley B, Ta C, Barnes S, de Jong E, Nguyen M, Cheung LC, Buzzai A, Wagner T, Wylie B, Fernandez S, Cruickshank M, Endersby R, Kees U, Waithman J. Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia. Clin Transl Immunology. 2020 Jul 16;9(7):e1151. doi: 10.1002/cti2.1151. eCollection 2020. PMID: 32695339; PMCID: PMC7365579.
Copy Download .nbib Format: NLM
Impact of COVID-19 on the Speech and Language Therapy Profession and Their Patients.

Frontiers in neurology

Chadd K, Moyse K, Enderby P.
PMID: 33679590
Front Neurol. 2021 Feb 18;12:629190. doi: 10.3389/fneur.2021.629190. eCollection 2021.

No abstract available.

Cite
Chadd K, Moyse K, Enderby P. Impact of COVID-19 on the Speech and Language Therapy Profession and Their Patients. Front Neurol. 2021;12:629190doi: 10.3389/fneur.2021.629190.
Chadd, K., Moyse, K., & Enderby, P. (2021). Impact of COVID-19 on the Speech and Language Therapy Profession and Their Patients. Frontiers in neurology, 12629190. https://doi.org/10.3389/fneur.2021.629190
Chadd, Katie, et al. "Impact of COVID-19 on the Speech and Language Therapy Profession and Their Patients." Frontiers in neurology vol. 12 (2021): 629190. doi: https://doi.org/10.3389/fneur.2021.629190
Chadd K, Moyse K, Enderby P. Impact of COVID-19 on the Speech and Language Therapy Profession and Their Patients. Front Neurol. 2021 Feb 18;12:629190. doi: 10.3389/fneur.2021.629190. eCollection 2021. PMID: 33679590; PMCID: PMC7930219.
Copy Download .nbib Format: NLM
Editors' Notes.

New directions for student leadership

Ahlquist J, Endersby L.
PMID: 28199058
New Dir Stud Leadersh. 2017 Mar;2017(153):5-8. doi: 10.1002/yd.20225.

No abstract available.

Cite
Ahlquist J, Endersby L. Editors' Notes. New Dir Stud Leadersh. 2017;2017(153):5-8doi: 10.1002/yd.20225.
Ahlquist, J., & Endersby, L. (2017). Editors' Notes. New directions for student leadership, 2017(153), 5-8. https://doi.org/10.1002/yd.20225
Ahlquist, Josie, and Endersby, Lisa. "Editors' Notes." New directions for student leadership vol. 2017,153 (2017): 5-8. doi: https://doi.org/10.1002/yd.20225
Ahlquist J, Endersby L. Editors' Notes. New Dir Stud Leadersh. 2017 Mar;2017(153):5-8. doi: 10.1002/yd.20225. PMID: 28199058.
Copy Download .nbib Format: NLM
Predictors and outcomes of speech and language therapists' treatment decisions.

International journal of speech-language pathology

Roulstone S, Peters TJ, Glogowska M, Enderby P.
PMID: 20840048
Int J Speech Lang Pathol. 2008;10(3):146-55. doi: 10.1080/17549500801894362.

This study investigated predictors of decisions made by speech and language therapists (SLTs) to offer intervention for pre-school children and the children's outcomes relative to that decision. The study uses data from 347 children who were first assessed aged...

Cite
Roulstone S, Peters TJ, Glogowska M, et al. Predictors and outcomes of speech and language therapists' treatment decisions. Int J Speech Lang Pathol. 2008;10(3):146-55doi: 10.1080/17549500801894362.
Roulstone, S., Peters, T. J., Glogowska, M., & Enderby, P. (2008). Predictors and outcomes of speech and language therapists' treatment decisions. International journal of speech-language pathology, 10(3), 146-55. https://doi.org/10.1080/17549500801894362
Roulstone, Sue, et al. "Predictors and outcomes of speech and language therapists' treatment decisions." International journal of speech-language pathology vol. 10,3 (2008): 146-55. doi: https://doi.org/10.1080/17549500801894362
Roulstone S, Peters TJ, Glogowska M, Enderby P. Predictors and outcomes of speech and language therapists' treatment decisions. Int J Speech Lang Pathol. 2008;10(3):146-55. doi: 10.1080/17549500801894362. PMID: 20840048.
Copy Download .nbib Format: NLM
Predictors of Effect of Atypical Antipsychotics on Speech.

Indian journal of psychological medicine

Sinha P, Vandana VP, Lewis NV, Jayaram M, Enderby P.
PMID: 26702176
Indian J Psychol Med. 2015 Oct-Dec;37(4):429-33. doi: 10.4103/0253-7176.168586.

BACKGROUND: Most of the studies have looked into the effect of typical antipsychotics on speech secondary to tardive dyskinesia.AIMS: This study was aimed to explore the factors predicting the effect of atypical antipsychotic medications on the production of speech.MATERIALS...

Cite
Sinha P, Vandana VP, Lewis NV, et al. Predictors of Effect of Atypical Antipsychotics on Speech. Indian J Psychol Med. 2015;37(4):429-33doi: 10.4103/0253-7176.168586.
Sinha, P., Vandana, V. P., Lewis, N. V., Jayaram, M., & Enderby, P. (2015). Predictors of Effect of Atypical Antipsychotics on Speech. Indian journal of psychological medicine, 37(4), 429-33. https://doi.org/10.4103/0253-7176.168586
Sinha, Preeti, et al. "Predictors of Effect of Atypical Antipsychotics on Speech." Indian journal of psychological medicine vol. 37,4 (2015): 429-33. doi: https://doi.org/10.4103/0253-7176.168586
Sinha P, Vandana VP, Lewis NV, Jayaram M, Enderby P. Predictors of Effect of Atypical Antipsychotics on Speech. Indian J Psychol Med. 2015 Oct-Dec;37(4):429-33. doi: 10.4103/0253-7176.168586. PMID: 26702176; PMCID: PMC4676210.
Copy Download .nbib Format: NLM
Deceived by orchids: sex, science, fiction and Darwin.

British journal for the history of science

Endersby J.
PMID: 27278105
Br J Hist Sci. 2016 Jun;49(2):205-29. doi: 10.1017/S0007087416000352. Epub 2016 Jun 09.

Between 1916 and 1927, botanists in several countries independently resolved three problems that had mystified earlier naturalists - including Charles Darwin: how did the many species of orchid that did not produce nectar persuade insects to pollinate them? Why...

Cite
Endersby J. Deceived by orchids: sex, science, fiction and Darwin. Br J Hist Sci. 2016;49(2):205-29doi: 10.1017/S0007087416000352.
Endersby, J. (2016). Deceived by orchids: sex, science, fiction and Darwin. British journal for the history of science, 49(2), 205-29. https://doi.org/10.1017/S0007087416000352
Endersby, Jim. "Deceived by orchids: sex, science, fiction and Darwin." British journal for the history of science vol. 49,2 (2016): 205-29. doi: https://doi.org/10.1017/S0007087416000352
Endersby J. Deceived by orchids: sex, science, fiction and Darwin. Br J Hist Sci. 2016 Jun;49(2):205-29. doi: 10.1017/S0007087416000352. Epub 2016 Jun 09. PMID: 27278105.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries